Skandinaviska Enskilda Banken (SEB)
FMTX

Skandinaviska Enskilda Banken (SEB)’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-41,505
Closed -$828K – 936
2022
Q3 		$828K Buy
+41,505
New +$547K 0.01% 710

Skandinaviska Enskilda Banken (SEB)'s FMTX Position: Q4 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 41,505 shares — an estimated $828K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $828K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 41,505 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $828K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Forma Therapeutics Holdings, Inc. Common Stock position peaked at $828K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2022, filed 8 Feb 2023.